Legal challenges to the 340B drug pricing program: administration, regulation, and reform.

ABSTRACT: The 340B Drug Pricing Program ("340B Program") was created to help safety net hospitals and clinics "stretch scarce federal resources" by discounting the price of their outpatient drug purchases. The spread between the discounted price and the sales price of the drug is retained by the hospitals and clinics, subsidizing operational costs and funding services that would not otherwise be possible to provide. The 340B Program has grown dramatically since its inception, eliciting significant criticism and calls for reform. Many legal challenges against the 340B Program and the agency tasked with administering the program-the Health Resources and Services Administration (HRSA)-have been brought, highlighting the limitations in HRSA's powers. Specifically, HRSA's lack of broad regulatory authori

SUBMITTER: Knox RP 

PROVIDER: S-EPMC12319670 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature